Fine-mapping and candidate gene investigation within the PARK10 locus

@article{Haugarvoll2009FinemappingAC,
  title={Fine-mapping and candidate gene investigation within the PARK10 locus},
  author={K. Haugarvoll and Mathias Toft and L. Skipper and M. Heckman and J. Crook and A. Soto and O. Ross and M. Hulihan and J. Kachergus and S. Sando and L. White and T. Lynch and J. Gibson and R. Uitti and Z. Wszolek and J. Aasly and M. Farrer},
  journal={European Journal of Human Genetics},
  year={2009},
  volume={17},
  pages={336-343}
}
  • K. Haugarvoll, Mathias Toft, +14 authors M. Farrer
  • Published 2009
  • Biology, Medicine
  • European Journal of Human Genetics
  • Herein, we investigate whether single-nucleotide polymorphisms (SNPs) across the PARK10 locus are associated with susceptibility to Parkinson's disease (PD) or age at onset (AAO) of disease. One hundred and eighty-eight SNPs were genotyped across the PARK10 locus in 180 PD patients and 180 controls from central Norway (stage 1). We then used the linkage disequilibrium (LD) structure from stage 1 to select 75 SNPs for genotyping in 186 patients and 186 controls from Ireland (stage 2). Nineteen… CONTINUE READING
    26 Citations
    Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease
    • 403
    • PDF
    Ubiquitin specific proteases USP24 and USP40 and ubiquitin thiolesterase UCHL1 polymorphisms have synergic effect on the risk of Parkinson's disease among Taiwanese.
    • Y. Wu, C. Chen, +6 authors G. Lee-Chen
    • Biology, Medicine
    • Clinica chimica acta; international journal of clinical chemistry
    • 2010
    • 21
    • PDF

    References

    SHOWING 1-10 OF 32 REFERENCES
    Investigation of the PARK10 Gene in Parkinson Disease
    • 16
    Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.
    • 66
    High-resolution whole-genome association study of Parkinson disease.
    • 500
    • PDF
    Age at onset in two common neurodegenerative diseases is genetically controlled.
    • 317
    • PDF